Medicamen Biotech Ltd.

NSE: MEDICAMEQ | BSE: 531146 | ASM

Mid-range Performer

Download real time

269.55 2.70 (1.01%)

39.94% Fall from 52W High

7,467 NSE+BSE Volume

NSE 22 May, 2026 3:31 PM (IST)

365.6

Market Cap

Below industry Median

-

Beta 1Year

Average volatility

Board Meeting

The next board meeting for Medicamen Biotech is on 27 May 2026 for the purpose of Final Dividend See details

Medicamen Biotech Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MEDICAMEQ, BSE:531146 Medicamen Biotech Ltd.

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%